Lawrentschuk N - Search Results

1

Modern paradigms for prostate cancer detection and management.

Williams IS, McVey A, Perera S, O'Brien JS, Kostos L, Chen K, Siva S, Azad AA, Murphy DG, Kasivisvanathan V, Lawrentschuk N, Frydenberg M. Williams IS, et al. Among authors: lawrentschuk n. Med J Aust. 2022 Oct 17;217(8):424-433. doi: 10.5694/mja2.51722. Epub 2022 Oct 2. Med J Aust. 2022. PMID: 36183329 Free PMC article. Review.

2

PET in prostate and bladder tumors.

Lee ST, Lawrentschuk N, Scott AM. Lee ST, et al. Among authors: lawrentschuk n. Semin Nucl Med. 2012 Jul;42(4):231-46. doi: 10.1053/j.semnuclmed.2012.03.002. Semin Nucl Med. 2012. PMID: 22681672 Review.

3

Gene expression profiling of localized prostate cancer: getting answers to the questions that really matter.

Azad A, Tran B, Sengupta S, Lawrentschuk N. Azad A, et al. Among authors: lawrentschuk n. J Clin Oncol. 2013 Sep 10;31(26):3295-6. doi: 10.1200/JCO.2013.51.0420. Epub 2013 Aug 12. J Clin Oncol. 2013. PMID: 23940217 No abstract available.

4

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer.

Thompson J, Lawrentschuk N, Frydenberg M, Thompson L, Stricker P; USANZ. Thompson J, et al. Among authors: lawrentschuk n. BJU Int. 2013 Nov;112 Suppl 2:6-20. doi: 10.1111/bju.12381. BJU Int. 2013. PMID: 24127671 Review.

5

The dilemmas of prostate cancer screening.

Lawrentschuk N, Murphy DG, Costello AJ. Lawrentschuk N, et al. Med J Aust. 2013 Nov 4;199(9):583. doi: 10.5694/mja13.10779. Med J Aust. 2013. PMID: 24182216 No abstract available.

6

Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?

Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, O'Reilly M, Murphy D. Grummet JP, et al. Among authors: lawrentschuk n. BJU Int. 2014 Sep;114(3):384-8. doi: 10.1111/bju.12536. Epub 2014 Feb 19. BJU Int. 2014. PMID: 24612341 Review.

7

Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes.

Eapen R, Liew MS, Tafreshi A, Papa N, Lawrentschuk N, Azad A, Davis ID, Bolton D, Sengupta S. Eapen R, et al. Among authors: lawrentschuk n. ANZ J Surg. 2015 Jul-Aug;85(7-8):535-9. doi: 10.1111/ans.12772. Epub 2014 Jul 14. ANZ J Surg. 2015. PMID: 25040795

8

Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre--impact on clinical decision-making and implications for patient inclusion.

Rao K, Manya K, Azad A, Lawrentschuk N, Bolton D, Davis ID, Sengupta S. Rao K, et al. Among authors: lawrentschuk n. BJU Int. 2014 Nov;114 Suppl 1:50-4. doi: 10.1111/bju.12764. Epub 2014 Jul 29. BJU Int. 2014. PMID: 25070295

9

The social media revolution is changing the conference experience: analytics and trends from eight international meetings.

Wilkinson SE, Basto MY, Perovic G, Lawrentschuk N, Murphy DG. Wilkinson SE, et al. Among authors: lawrentschuk n. BJU Int. 2015 May;115(5):839-46. doi: 10.1111/bju.12910. Epub 2015 Jan 26. BJU Int. 2015. PMID: 25130687

10

Emerging trends in prostate cancer literature: medical progress or marketing hype?

Lo J, Papa N, Bolton DM, Murphy D, Lawrentschuk N. Lo J, et al. Among authors: lawrentschuk n. BJU Int. 2016 Jan;117(1):14-6. doi: 10.1111/bju.13015. Epub 2015 Jun 11. BJU Int. 2016. PMID: 25496244 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

596 results

Search Page